Exceptional Response to MEK Inhibition in a Patient With RAF1-Mutant Myxofibrosarcoma: Case Report and Mechanistic Overview.

Özgü E, Aydin E, Adibi A, Tokat ÜM, Tutar O, Hu J, Demiray I, Kurzrock R, Demiray M

Open source

DOI
10.1200/po.23.00299
Published
2023 Sep
Container
JCO precision oncology
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1200/po.23.00299,
  title = {Exceptional Response to MEK Inhibition in a Patient With RAF1-Mutant Myxofibrosarcoma: Case Report and Mechanistic Overview.},
  author = {Özgü E and Aydin E and Adibi A and Tokat ÜM and Tutar O and Hu J and Demiray I and Kurzrock R and Demiray M},
  year = {2023},
  journal = {JCO precision oncology},
  doi = {10.1200/po.23.00299},
  url = {https://doi.org/10.1200/po.23.00299}
}

RIS

TY  - JOUR
TI  - Exceptional Response to MEK Inhibition in a Patient With RAF1-Mutant Myxofibrosarcoma: Case Report and Mechanistic Overview.
AU  - Özgü E
AU  - Aydin E
AU  - Adibi A
AU  - Tokat ÜM
AU  - Tutar O
AU  - Hu J
AU  - Demiray I
AU  - Kurzrock R
AU  - Demiray M
PY  - 2023
JO  - JCO precision oncology
DO  - 10.1200/po.23.00299
UR  - https://doi.org/10.1200/po.23.00299
ER  - 

APA

E, Ö., E, A., A, A., ÜM, T., O, T., J, H., I, D., R, K., & M, D. (2023). Exceptional Response to MEK Inhibition in a Patient With RAF1-Mutant Myxofibrosarcoma: Case Report and Mechanistic Overview.. JCO precision oncology. https://doi.org/10.1200/po.23.00299

Source records